Radiotherapy for T1a glottic cancer: The influence of smoking cessation and fractionation schedule of radiotherapy

European Archives of Oto-Rhino-Laryngology

Volumn 271, Issue 1, 2014, Pages 125-132

  Al Mamgani, Abrahim ^a   Van Rooij, Peter H ^a   Mehilal, Robert ^a   Verduijn, Gerda M ^a   Tans, Lisa ^a   Kwa, Stefan L S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Glottic cancer; Quality of life; Radiotherapy; T1a; Voice handicap index

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DYSPHAGIA; DYSPNEA; FEMALE; FOLLOW UP; FOOD ASPIRATION; HUMAN; LARYNX CANCER; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIATION INDUCED HYPOTHYROIDISM; RADIATION INJURY; RETROSPECTIVE STUDY; SECOND CANCER; SMOKING CESSATION; TISSUE NECROSIS; VERY ELDERLY; VOICE HANDICAP INDEX; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; GLOTTIS; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; QUALITY OF LIFE; SMOKING CESSATION; TREATMENT OUTCOME; XEROSTOMIA;

EID: 84892913021     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-013-2608-8     Document Type: Article

References (16)

1. www.oncoline.nl/larynxcarcinoom
2. Hartl DM, Ferlito A, Brasnu DF, Langendijk JA, Rinaldo A, Silver CE, Wolf GT (2011) Evidence-based review of treatment options for patients with glottic cancer. Head Neck 11:1638-1648
3. Rosen CA, Lee AS, Osborne J, Zullo T, Murry T (2004) Development and validation of the voice handicap index-10. Laryngoscope 114:1549-1556
4. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB (2004) Management of T1-T2 glottic carcinomas. Cancer 100:1786-1792
5. van Loon Y, Sjögren EV, Langeveld TP, Baatenburg de Jong RJ, Schoones JW, van Rossum MA (2012) Functional outcomes after radiotherapy or laser surgery in early glottic carcinoma: a systematic review. Head Neck 34:1179-1189
6. Cohen SM, Garrett CG, Dupont WD, Ossoff RH, Courey MS (2006) Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. Ann Otol Rhinol Laryngol 115:581-586
7. Sjogren EV, van Rossum MA, Langeveld TPM, Voerman MS, van de Kamp VA, Friebel MO, Wolterbeek R, Baatenburg de Jong RJ (2008) Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg 134:965-972
8. Sjögren EV, van Rossum MA, Langeveld TP, Voerman MS, van de Kamp VA, Baatenburg de Jong RJ (2009) Voice profile after type I or II laser chordectomies for T1a glottic carcinoma. Head Neck 31:1502-1510
9. Terhaard CH, Snippe K, Ravasz LA, van der Tweel I, Hordijk GJ (1991) Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni-and multivariate analysis. Int J Radiat Oncol Biol Phys 21:1179-1186
10. Van der voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H (1998) The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys 42:247-255
11. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J, Andersen L, Evensen JF (2003) Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362:933-940
12. Laskar SG, Baijal G, Murthy V, Chilukuri S, Budrukkar A, Gupta T, Agarwal JP (2012) Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution. Clin Oncol 24:e180-e186
13. Wiernik G, Alcock CJ, Bates TD, Brindle JM, Fowler JF, Gajek WR, Goodman S, Haybittle JL, Henk JM, Hopewell JW (1991) Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngopharynx. Br J Radiol 64:232-241
14. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ (2003) Three weeks radiotherapy for T1 glottic cancer: the Christie and royal marsden hospital experience. Radiother Oncol 682:105-111
15. Osman SOS, Astreinidou E, De Boer HCJ, Keskin-Cambay F, Breedveld S, Voet P, Al-Mamgani A, Heijmen BJ, Levendag PC (2012) IMRT for image-guided single vocal cord irradiation. Int J Radiat Oncol Biol Phys 2012(82):989-997
16. Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, Waldron J, Cummings BJ (1998) T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment haemoglobin on local control. Int J Radiat Oncol Biol Phys 41: 347-353